| UniProt ID | ZN267_HUMAN | |
|---|---|---|
| UniProt AC | Q14586 | |
| Protein Name | Zinc finger protein 267 | |
| Gene Name | ZNF267 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 743 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | May be involved in transcriptional regulation.. | |
| Protein Sequence | MGLLTFRDVAVEFSLEEWEHLEPAQKNLYQDVMLENYRNLVSLGLVVSKPDLITFLEQRKEPWNVKSEETVAIQPDVFSHYNKDLLTEHCTEASFQKVISRRHGSCDLENLHLRKRWKREECEGHNGCYDEKTFKYDQFDESSVESLFHQQILSSCAKSYNFDQYRKVFTHSSLLNQQEEIDIWGKHHIYDKTSVLFRQVSTLNSYRNVFIGEKNYHCNNSEKTLNQSSSPKNHQENYFLEKQYKCKEFEEVFLQSMHGQEKQEQSYKCNKCVEVCTQSLKHIQHQTIHIRENSYSYNKYDKDLSQSSNLRKQIIHNEEKPYKCEKCGDSLNHSLHLTQHQIIPTEEKPCKWKECGKVFNLNCSLYLTKQQQIDTGENLYKCKACSKSFTRSSNLIVHQRIHTGEKPYKCKECGKAFRCSSYLTKHKRIHTGEKPYKCKECGKAFNRSSCLTQHQTTHTGEKLYKCKVCSKSYARSSNLIMHQRVHTGEKPYKCKECGKVFSRSSCLTQHRKIHTGENLYKCKVCAKPFTCFSNLIVHERIHTGEKPYKCKECGKAFPYSSHLIRHHRIHTGEKPYKCKACSKSFSDSSGLTVHRRTHTGEKPYTCKECGKAFSYSSDVIQHRRIHTGQRPYKCEECGKAFNYRSYLTTHQRSHTGERPYKCEECGKAFNSRSYLTTHRRRHTGERPYKCDECGKAFSYRSYLTTHRRSHSGERPYKCEECGKAFNSRSYLIAHQRSHTREKL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 34 | Ubiquitination | NLYQDVMLENYRNLV HHHHHHHHHHHHHHH | 3.76 | 29967540 | |
| 51 | Ubiquitination | GLVVSKPDLITFLEQ CCEECCHHHHHHHHH | 55.21 | 29967540 | |
| 54 | Phosphorylation | VSKPDLITFLEQRKE ECCHHHHHHHHHCCC | 29.48 | 21406692 | |
| 60 | Ubiquitination | ITFLEQRKEPWNVKS HHHHHHCCCCCCCCC | 68.75 | - | |
| 65 | Ubiquitination | QRKEPWNVKSEETVA HCCCCCCCCCCEEEE | 6.79 | 29967540 | |
| 66 | Sumoylation | RKEPWNVKSEETVAI CCCCCCCCCCEEEEE | 49.27 | - | |
| 66 | Ubiquitination | RKEPWNVKSEETVAI CCCCCCCCCCEEEEE | 49.27 | 29967540 | |
| 66 | Sumoylation | RKEPWNVKSEETVAI CCCCCCCCCCEEEEE | 49.27 | 28112733 | |
| 70 | Phosphorylation | WNVKSEETVAIQPDV CCCCCCEEEEECCCH | 15.93 | 23879269 | |
| 83 | Ubiquitination | DVFSHYNKDLLTEHC CHHHHCCHHHHHHHC | 42.46 | 29967540 | |
| 97 | Ubiquitination | CTEASFQKVISRRHG CCHHHHHHHHHHHCC | 39.25 | 29967540 | |
| 103 | Ubiquitination | QKVISRRHGSCDLEN HHHHHHHCCCCCHHH | 31.26 | 29967540 | |
| 105 | Phosphorylation | VISRRHGSCDLENLH HHHHHCCCCCHHHHH | 9.80 | 21712546 | |
| 126 | Ubiquitination | REECEGHNGCYDEKT HHHCCCCCCCCCCCC | 53.76 | 29967540 | |
| 135 | Sumoylation | CYDEKTFKYDQFDES CCCCCCEECCCCCHH | 53.82 | 28112733 | |
| 135 | Ubiquitination | CYDEKTFKYDQFDES CCCCCCEECCCCCHH | 53.82 | 29967540 | |
| 154 | Ubiquitination | LFHQQILSSCAKSYN HHHHHHHHHHHHHCC | 25.63 | 29967540 | |
| 158 | Ubiquitination | QILSSCAKSYNFDQY HHHHHHHHHCCHHHH | 58.77 | 29967540 | |
| 159 | Phosphorylation | ILSSCAKSYNFDQYR HHHHHHHHCCHHHHH | 13.54 | 30108239 | |
| 160 | Phosphorylation | LSSCAKSYNFDQYRK HHHHHHHCCHHHHHH | 21.10 | 30108239 | |
| 186 | Ubiquitination | EEIDIWGKHHIYDKT HHEEECCCCCCCCHH | 19.60 | 29967540 | |
| 191 | Ubiquitination | WGKHHIYDKTSVLFR CCCCCCCCHHHHHEE | 47.34 | 29967540 | |
| 194 | Phosphorylation | HHIYDKTSVLFRQVS CCCCCHHHHHEEEHH | 23.67 | - | |
| 200 | Ubiquitination | TSVLFRQVSTLNSYR HHHHEEEHHHHHHCC | 4.04 | 29967540 | |
| 201 | Phosphorylation | SVLFRQVSTLNSYRN HHHEEEHHHHHHCCC | 20.88 | 30576142 | |
| 210 | Ubiquitination | LNSYRNVFIGEKNYH HHHCCCEEECCCCEE | 7.29 | 29967540 | |
| 214 | Ubiquitination | RNVFIGEKNYHCNNS CCEEECCCCEECCCC | 58.56 | - | |
| 223 | Ubiquitination | YHCNNSEKTLNQSSS EECCCCCCCCCCCCC | 59.12 | 29967540 | |
| 224 | Phosphorylation | HCNNSEKTLNQSSSP ECCCCCCCCCCCCCC | 27.22 | 23312004 | |
| 228 | Phosphorylation | SEKTLNQSSSPKNHQ CCCCCCCCCCCCCHH | 31.54 | 30108239 | |
| 229 | Phosphorylation | EKTLNQSSSPKNHQE CCCCCCCCCCCCHHH | 40.68 | 30108239 | |
| 230 | Phosphorylation | KTLNQSSSPKNHQEN CCCCCCCCCCCHHHH | 45.18 | 25849741 | |
| 230 | Ubiquitination | KTLNQSSSPKNHQEN CCCCCCCCCCCHHHH | 45.18 | 29967540 | |
| 232 | Ubiquitination | LNQSSSPKNHQENYF CCCCCCCCCHHHHHH | 69.84 | 29967540 | |
| 238 | Phosphorylation | PKNHQENYFLEKQYK CCCHHHHHHHHHHHH | 14.59 | 30108239 | |
| 242 | Ubiquitination | QENYFLEKQYKCKEF HHHHHHHHHHHCHHH | 62.16 | 29967540 | |
| 262 | Ubiquitination | QSMHGQEKQEQSYKC HHHCCHHHHHHHHCC | 51.77 | 29967540 | |
| 270 | Ubiquitination | QEQSYKCNKCVEVCT HHHHHCCCHHHHHHH | 36.29 | 29967540 | |
| 280 | Ubiquitination | VEVCTQSLKHIQHQT HHHHHHHHHHHCCCE | 3.17 | 29967540 | |
| 288 | Ubiquitination | KHIQHQTIHIRENSY HHHCCCEEEEECCCC | 1.73 | 29967540 | |
| 302 | Ubiquitination | YSYNKYDKDLSQSSN CCCCCCCCCCHHCCC | 58.44 | 29967540 | |
| 312 | Ubiquitination | SQSSNLRKQIIHNEE HHCCCHHHHHHHCCC | 49.36 | 29967540 | |
| 320 | Ubiquitination | QIIHNEEKPYKCEKC HHHHCCCCCCCCCCC | 47.68 | 29967540 | |
| 337 | Ubiquitination | SLNHSLHLTQHQIIP CCCCCEECCCCCCCC | 6.30 | 29967540 | |
| 349 | Ubiquitination | IIPTEEKPCKWKECG CCCCCCCCCCCCCCC | 28.35 | 29967540 | |
| 364 | Phosphorylation | KVFNLNCSLYLTKQQ CEEECCCEEEEEECC | 20.98 | 30108239 | |
| 366 | Phosphorylation | FNLNCSLYLTKQQQI EECCCEEEEEECCCC | 8.95 | 30108239 | |
| 368 | Phosphorylation | LNCSLYLTKQQQIDT CCCEEEEEECCCCCC | 17.16 | 30108239 | |
| 369 | Ubiquitination | NCSLYLTKQQQIDTG CCEEEEEECCCCCCC | 43.44 | 29967540 | |
| 381 | Ubiquitination | DTGENLYKCKACSKS CCCCCCEECCCCCCC | 32.21 | 29967540 | |
| 403 | Phosphorylation | IVHQRIHTGEKPYKC EEEEEEECCCCCCCC | 44.67 | 29496963 | |
| 408 | Phosphorylation | IHTGEKPYKCKECGK EECCCCCCCCCCCCC | 39.83 | - | |
| 424 | Phosphorylation | FRCSSYLTKHKRIHT CCCHHHHHCCCCCCC | 23.91 | 22817900 | |
| 430 | Ubiquitination | LTKHKRIHTGEKPYK HHCCCCCCCCCCCCC | 31.67 | 29967540 | |
| 431 | Phosphorylation | TKHKRIHTGEKPYKC HCCCCCCCCCCCCCC | 44.67 | 29496963 | |
| 436 | Phosphorylation | IHTGEKPYKCKECGK CCCCCCCCCCCHHHC | 39.83 | - | |
| 456 | Phosphorylation | SCLTQHQTTHTGEKL HCCCCCCCCCCCCEE | 20.58 | 28555341 | |
| 462 | Ubiquitination | QTTHTGEKLYKCKVC CCCCCCCEEEECEEC | 59.46 | 29967540 | |
| 487 | Phosphorylation | IMHQRVHTGEKPYKC EEEEECCCCCCCCCC | 44.15 | 29496963 | |
| 490 | Sumoylation | QRVHTGEKPYKCKEC EECCCCCCCCCCCCC | 55.80 | - | |
| 490 | Ubiquitination | QRVHTGEKPYKCKEC EECCCCCCCCCCCCC | 55.80 | - | |
| 490 | Sumoylation | QRVHTGEKPYKCKEC EECCCCCCCCCCCCC | 55.80 | - | |
| 502 | Phosphorylation | KECGKVFSRSSCLTQ CCCCCEECCHHHHHC | 33.95 | 24719451 | |
| 505 | Phosphorylation | GKVFSRSSCLTQHRK CCEECCHHHHHCCCC | 16.43 | 24719451 | |
| 512 | Ubiquitination | SCLTQHRKIHTGENL HHHHCCCCCCCCCCC | 36.39 | - | |
| 515 | Phosphorylation | TQHRKIHTGENLYKC HCCCCCCCCCCCEEC | 50.06 | 25159151 | |
| 520 | Phosphorylation | IHTGENLYKCKVCAK CCCCCCCEECEECCC | 26.39 | 22817900 | |
| 543 | Phosphorylation | IVHERIHTGEKPYKC EEEEECCCCCCCEEC | 44.67 | 29496963 | |
| 548 | Phosphorylation | IHTGEKPYKCKECGK CCCCCCCEECCCCCC | 39.83 | - | |
| 568 | Methylation | SHLIRHHRIHTGEKP HHHHHCCCCCCCCCC | 19.09 | 24381517 | |
| 571 | Phosphorylation | IRHHRIHTGEKPYKC HHCCCCCCCCCCCCC | 44.67 | 29496963 | |
| 582 | Phosphorylation | PYKCKACSKSFSDSS CCCCCCCCCCCCCCC | 35.87 | 28842319 | |
| 584 | Phosphorylation | KCKACSKSFSDSSGL CCCCCCCCCCCCCCC | 17.43 | 28555341 | |
| 586 | Phosphorylation | KACSKSFSDSSGLTV CCCCCCCCCCCCCEE | 43.61 | 30108239 | |
| 588 | Phosphorylation | CSKSFSDSSGLTVHR CCCCCCCCCCCEEEC | 25.71 | 30108239 | |
| 589 | Phosphorylation | SKSFSDSSGLTVHRR CCCCCCCCCCEEECC | 42.69 | 30108239 | |
| 597 | Phosphorylation | GLTVHRRTHTGEKPY CCEEECCCCCCCCCE | 24.60 | - | |
| 599 | Phosphorylation | TVHRRTHTGEKPYTC EEECCCCCCCCCEEC | 46.56 | - | |
| 604 | Phosphorylation | THTGEKPYTCKECGK CCCCCCCEECCCCCC | 35.52 | - | |
| 605 | Phosphorylation | HTGEKPYTCKECGKA CCCCCCEECCCCCCE | 26.15 | - | |
| 614 | Phosphorylation | KECGKAFSYSSDVIQ CCCCCEEECCCCCHH | 29.03 | 30301811 | |
| 615 | Phosphorylation | ECGKAFSYSSDVIQH CCCCEEECCCCCHHC | 13.02 | 22817900 | |
| 616 | Phosphorylation | CGKAFSYSSDVIQHR CCCEEECCCCCHHCC | 20.90 | 30301811 | |
| 617 | Phosphorylation | GKAFSYSSDVIQHRR CCEEECCCCCHHCCC | 27.88 | 30301811 | |
| 633 | Sumoylation | HTGQRPYKCEECGKA CCCCCCEECHHCCCC | 37.54 | - | |
| 633 | Ubiquitination | HTGQRPYKCEECGKA CCCCCCEECHHCCCC | 37.54 | - | |
| 633 | Sumoylation | HTGQRPYKCEECGKA CCCCCCEECHHCCCC | 37.54 | - | |
| 653 | Phosphorylation | YLTTHQRSHTGERPY HCCCCCCCCCCCCCE | 20.87 | 27251275 | |
| 655 | Phosphorylation | TTHQRSHTGERPYKC CCCCCCCCCCCCEEH | 41.82 | 27251275 | |
| 661 | Sumoylation | HTGERPYKCEECGKA CCCCCCEEHHHCCHH | 37.54 | - | |
| 661 | Sumoylation | HTGERPYKCEECGKA CCCCCCEEHHHCCHH | 37.54 | - | |
| 661 | Ubiquitination | HTGERPYKCEECGKA CCCCCCEEHHHCCHH | 37.54 | - | |
| 667 | Ubiquitination | YKCEECGKAFNSRSY EEHHHCCHHHCCCCC | 62.56 | - | |
| 688 | Phosphorylation | RHTGERPYKCDECGK CCCCCCCCCCCCCCC | 30.39 | - | |
| 699 | Phosphorylation | ECGKAFSYRSYLTTH CCCCCEEEHHHHHCC | 9.34 | - | |
| 717 | Ubiquitination | HSGERPYKCEECGKA CCCCCCCCHHHHHHH | 37.54 | - | |
| 717 | Sumoylation | HSGERPYKCEECGKA CCCCCCCCHHHHHHH | 37.54 | - | |
| 717 | Sumoylation | HSGERPYKCEECGKA CCCCCCCCHHHHHHH | 37.54 | - | |
| 723 | Ubiquitination | YKCEECGKAFNSRSY CCHHHHHHHHCCCCH | 62.56 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN267_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN267_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN267_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of ZN267_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-424, AND MASSSPECTROMETRY. | |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-520, AND MASSSPECTROMETRY. | |